Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth

• Freedom Capital Markets has lowered its stock price target for VolitionRX due to concerns over delayed revenue growth. This adjustment reflects a negative sentiment towards the company's financial performance and future prospects.
• This development is significant as it may impact investor confidence in VolitionRX, potentially leading to a decrease in stock value and affecting the company's ability to raise capital for future projects and initiatives.

— via World Pulse Now AI Editorial System